FRANCIS DIMARIO, MD

Plain English
Researchers studied ancient human remains found in Guattari Cave in Italy, dating back about 66,000 to 65,000 years. They discovered that these remains show a mix of both ancient (primitive) and more recent (derived) traits, indicating that the population was quite diverse and had connections to different early human groups, including Neanderthals. This matters because it helps us understand how early humans evolved and interacted in Eurasia, especially in the Mediterranean, which was key to human development. Who this helps: This benefits researchers and historians studying human evolution.

Plain English
This study looked at ways to prevent acute diverticulitis, a painful condition that affects the colon, in nearly 2,000 patients with newly diagnosed diverticular disease. Researchers followed the patients for three years and found that those on a high-fiber diet had a 5.9% risk of developing the condition, while patients taking mesalamine faced a 9.5% risk, and those on a combination of mesalamine and rifaximin had a 17.1% risk. Notably, mesalamine significantly reduced the risk of diverticulitis in patients with more severe inflammation, showing a 77% to 84% lower risk compared to other treatments. Who this helps: This research benefits patients suffering from diverticular disease by helping doctors choose better treatments to prevent diverticulitis.

Plain English
This study looked at the nutritional needs of patients with Acute Kidney Injury (AKI) to better understand how proper diet can help their recovery. Researchers found that inadequate nutrition can lead to a serious condition called protein energy wasting (PEW), which affects health and recovery; thus, they emphasize that tailored nutritional support can help maintain muscle mass, improve health outcomes, and may even aid in kidney function recovery. Specifically, addressing energy and protein needs is critical, especially in those who might require further kidney treatments. Who this helps: This helps patients with Acute Kidney Injury and their healthcare providers.

Plain English
This study looked at a method called Sustained Low-Efficiency Dialysis (SLED) using a specific anticoagulant and new dialysis equipment in critically ill patients. Researchers performed 81 dialysis sessions on 27 patients and found that 88% of sessions met the treatment time goal, with no major complications from the anticoagulant used. This is important because it shows that this method is both safe and effective in providing kidney support for critically ill patients, reducing the risk of complications and ensuring that treatment is tailored to their needs. Who this helps: Patients with kidney failure in intensive care units.

Plain English
This study looked at how well a specific dialysis method, called sustained low-efficiency dialysis (SLED) using regional citrate anticoagulation (RCA), works in treating patients with metformin-associated lactic acidosis (MALA), a serious condition linked to kidney problems. Researchers found that SLED effectively lowered dangerous metformin levels in the blood from an average of 27.75 mg/L to 3.95 mg/L and improved patients' overall health without causing harmful citrate buildup. Out of 23 patients studied, 22% died, but SLED offered an efficient way to manage their condition safely with minimal interruptions. Who this helps: This helps critically ill patients with kidney issues related to metformin use.

Plain English
This study looked at how to safely dose pain relief and sedation medications for critically ill patients who have Acute Kidney Injury and are undergoing different types of kidney replacement therapy. It highlighted that kidney issues can change how these medications work in the body, and when using treatments like hemodialysis, the way drugs are eliminated can change, requiring careful adjustments. The goal is to ensure these patients receive the right amount of medication to manage their pain and anxiety without causing harm. Who this helps: Patients with Acute Kidney Injury in intensive care settings.

Plain English
This study looked at how changes in bowel movements, like constipation and diarrhea, relate to the severity of diverticular disease (DD) and the risk of acute diverticulitis, a serious complication. Researchers studied 871 patients, finding that 24% had significant constipation and 23% had significant diarrhea. They discovered that worse constipation or diarrhea scores were linked to more severe DD and increased risk of acute diverticulitis, meaning a 1-point increase in bowel issue scores raised the risk by 15% for constipation and 14% for diarrhea. Who this helps: This benefits patients with diverticular disease by helping them understand their symptoms and manage their risk for complications.

Plain English
This study explored how to confirm a diagnosis of chronic atrophic gastritis (CAG), a condition that can increase the risk of stomach cancer, by using a test that involves proton pump inhibitors (PPIs). Researchers examined 102 patients with pepsinogen I (PG-I) levels between 30 and 50 mcg/L and found that a 30% increase in PG-I after using a PPI could accurately identify CAG in these patients, achieving a 95% positive predictive value. This method is important because it provides a non-invasive way to detect a potentially serious condition without more invasive procedures. Who this helps: This helps patients at risk for gastric cancer and their healthcare providers.

Plain English
This study looked at whether a specific probiotic called Lactobacillus paracasei CNCM I 1572 could help prevent acute diverticulitis (a painful inflammation of the colon) in patients who have mild diverticular disease. Out of 105 participants, only 1 patient taking the probiotic developed acute diverticulitis, compared to 6 patients in the placebo group, showing that the probiotic reduces the risk significantly (p=0.036). This discovery offers a potential new way to prevent complications in patients with diverticular disease. Who this helps: This benefits patients suffering from diverticular disease and their healthcare providers.

Plain English
This study looks at diverticular disease, a common condition where pouches form in the colon, affecting many people in developed countries. It found that while 20-25% of those with diverticulosis show symptoms, high fiber diets can reduce risk, while smoking and obesity increase it. The report provides clear recommendations for managing this condition, such as using dietary changes instead of routine antibiotics and focusing on individual patient needs for surgery. Who this helps: This helps patients with diverticular disease and their doctors.

Plain English
This study looked at how glucocorticoids, a type of anti-inflammatory medication, could be used to treat atheroembolic renal disease (ARD), which is caused by cholesterol crystals blocking blood flow to the kidneys. The research found that these crystals can trigger inflammation and cell damage in the kidneys, and while there's ongoing debate about the effectiveness of glucocorticoids in treating this condition, the study notes a lack of consistent evidence and clear guidelines, which can lead to worse outcomes for patients. Improving the use of glucocorticoids could potentially help address the poor prognosis associated with ARD. Who this helps: This research benefits patients suffering from atheroembolic renal disease and their healthcare providers.

Plain English
This study looked at how L-cysteine (Acetium®) affects symptoms in patients with chronic atrophic gastritis (CAG), a condition that can lead to stomach cancer. Researchers found that after two years, patients taking L-cysteine experienced a significant drop in symptom severity, with their average score improving from 7.8 to 4.5. In contrast, patients who did not receive the treatment showed no improvement at all, highlighting the potential of L-cysteine as a helpful long-term therapy for CAG symptoms. Who this helps: This helps patients with chronic atrophic gastritis by reducing their symptoms and improving their quality of life.

Plain English
This study looked at how well proton pump inhibitors (PPIs), a common type of medication for stomach issues, are being prescribed to patients. Researchers analyzed 2,583 patients, and found that 39.3% had been on PPI therapy for at least three months, with only 34.9% showing a good response to the medication. Many of these patients may not actually need the medication because their stomach function tests indicated that it wasn’t appropriate for them, which highlights the importance of checking for conditions like HP infection before starting long-term treatment with PPIs. Who this helps: This helps patients who might be on unnecessary PPI therapy and doctors who prescribe these medications.

Plain English
This study looked at a new simplified method for using citrate to prevent low phosphate levels in critically ill patients undergoing kidney replacement therapy (KRT). Researchers found that this approach resulted in a low rate of hypophosphatemia (only 6.6% of patients) and kept acid-base balance stable without any issues from citrate buildup. This is important because it helps ensure patients get safe and effective treatment while minimizing complications. Who this helps: Patients with acute kidney injury or end-stage kidney disease needing kidney replacement therapy.

Plain English
This study looked at how common a condition called segmental colitis associated with diverticulosis (SCAD) is among people newly diagnosed with diverticulosis. Out of 2,215 patients, 44 were found to have SCAD, which means it occurs in about 2% of these cases. Those with specific types of SCAD experienced worse symptoms and were less likely to fully recover compared to others. Who this helps: This information is useful for doctors treating patients with diverticulosis to better understand and manage the potential complications.

Plain English
This study looked at whether long-term use of proton pump inhibitors (PPIs), which reduce stomach acid, is linked to an increased risk of gastric cancer. The researchers found that previous studies had conflicting results, but issues like poor data collection and biases were likely affecting these findings. Overall, their analysis indicates that there's no clear evidence to support a direct link between long-term PPI use and the development of gastric cancer. Who this helps: This benefits patients who are prescribed PPIs and their doctors, as it clarifies the safety of these medications.

Plain English
This paper examined the use of regional citrate anticoagulation (RCA) in critically ill patients who need kidney support treatments. The experts found that RCA is a recommended and effective first-line strategy for preventing blood clots during these treatments, which is crucial since it helps maintain proper blood flow and patient safety. They emphasized the importance of careful monitoring for patients at higher risk and suggested improvements to ensure the therapy works well without causing imbalances in essential minerals. Who this helps: This helps patients undergoing renal replacement therapy and their medical teams.

Plain English
This study looked at how well two assessment methods, DICA and CODA, can predict complications in patients with diverticular disease, and whether measuring fecal calprotectin (FC) can improve those predictions. They followed 871 patients and found that higher levels of FC were linked to a greater risk of acute diverticulitis, specifically with a risk increase of 3.29 times for each tenfold increase in FC concentration within the first three years. While FC can help assess immediate risk of complications, the study suggests using DICA and CODA alone for longer-term treatment strategies, as they were more accurate overall. Who this helps: This research helps doctors better assess and manage patients with diverticular disease.

Plain English
This study examined different treatments for reflux esophagitis, a condition that causes heartburn and acid reflux. Researchers tested six treatment combinations on 211 patients over two months and found that using proton pump inhibitors (PPIs) combined with mucosal protective drugs led to the best improvement in symptoms, while treatments that included prokinetics had the highest dropout rate because of side effects. This matters because it gives clear guidance on which treatments work best for relieving GERD symptoms and can help inform better care options for patients. Who this helps: Patients suffering from gastroesophageal reflux disease.

Plain English
This study looked at how to treat patients with serious kidney issues who had too much dabigatran, a blood thinner that can cause bleeding problems. Researchers found that using a type of dialysis called Sustained Low-Efficiency Dialysis (SLED) successfully removed the drug from three patients' bodies in a single treatment session. This is important because it shows a promising way to safely manage dabigatran overdose in patients with Acute Kidney Injury, reducing their risk of complications. Who this helps: This helps patients with kidney problems who are taking dabigatran, as well as their doctors.

Plain English
This study looked at how muscle mass and the quality of muscle (specifically fat infiltration) affect the survival of critically ill patients with severe pneumonia due to Sars-Cov-2. Researchers examined 110 patients and found that those with higher levels of fat in their muscles had a significantly higher risk of death: for every 10% increase in fat, the risk of mortality rose by 101% for one type of fat measure and by 53% for another. This is important because it highlights muscle health as a key factor in determining the outcomes for patients in the ICU suffering from severe Sars-Cov-2 pneumonia. Who this helps: This helps doctors and healthcare providers identify at-risk patients and make better treatment decisions.

Plain English
This study looked at how well children with epilepsy can remember to do things in the future. Researchers found that kids with epilepsy scored lower on IQ tests and some memory tasks compared to healthy children, but all kids did better on tasks where they had to remember to act based on events rather than specific times. These findings are important because they highlight potential memory challenges in children with epilepsy, which can affect their daily lives and academic performance. Who this helps: This helps patients, particularly children with epilepsy, and their doctors.

Plain English
This study looked at the amount of skeletal muscle in patients with end-stage kidney disease who are on hemodialysis. Researchers found that patients with low muscle mass, as seen on CT scans, had a nearly 80% higher risk of dying compared to those with normal muscle mass. This matters because measuring muscle mass could help identify patients at higher risk of mortality, leading to better management and care strategies. Who this helps: This helps patients on hemodialysis and their healthcare providers.

Plain English
This study analyzed how well two systems—DICA and CODA—can predict complications for patients with diverticulosis, a condition affecting the intestine. It involved over 2,200 patients from various centers in Europe and South America. The findings showed that patients with higher DICA scores faced increased risks: for those with a DICA score of 3, the chance of needing surgery was 11% over three years, while it was just 0.15% for those with a score of 1. Understanding these scores is important because they help doctors identify which patients might face more severe complications, informing treatment decisions. Who this helps: This benefits patients with diverticulosis and their doctors.

Plain English
The study looked at patients who experienced acute kidney injury (AKI) in a hospital over a year and a half to understand their health outcomes. Out of 1,145 patients referred to kidneys specialists, 559 had AKI, with 43.3% dying within 90 days of admission, particularly at risk were older patients and those with low urine output. However, 96.4% of the patients who survived showed improvement in kidney function before leaving the hospital, and quick recovery of kidney function was linked to better chances of survival. Who this helps: This research benefits kidney patients and doctors by highlighting the importance of timely treatment for AKI.

Plain English
This study looked at a protein called pepsinogen II (PgII) in patients with gastritis and infections caused by Helicobacter pylori (H. pylori). The researchers found that patients infected with H. pylori had much higher PgII levels, with some studies showing p-values as low as 0.0001, indicating strong evidence. After treating H. pylori infections, PgII levels dropped significantly, but the test wasn't reliable enough to clearly determine if the treatment was successful. Who this helps: This benefits patients dealing with gastritis and doctors treating H. pylori infections.

Plain English
This study looked at 264 patients in Northern Italy with Barrett's esophagus, a condition that can lead to esophageal cancer, over an average follow-up of 6.7 years. The researchers found that regular endoscopic check-ups are essential for spotting changes that could lead to cancer; for example, those with high-risk factors like being male, smoking, or drinking heavily might especially benefit from close monitoring. This is important because early detection can significantly improve treatment outcomes and potentially save lives. Who this helps: This research helps patients with Barrett's esophagus and their doctors.

Plain English
This study looked at critically ill COVID-19 patients in the ICU to see how new kidney problems (acute kidney injury or AKI) affected their chances of survival, depending on how serious their condition was when they were admitted. They found that among patients with less severe symptoms at admission, those who developed AKI had a much higher risk of dying within 28 days (for instance, a 4.27 times greater risk for those in the lowest severity group). This is important because it shows that monitoring kidney health in patients with less severe COVID-19 can be crucial for improving their outcomes. Who this helps: This helps doctors treating COVID-19 patients to identify and manage those at higher risk of death due to kidney injury.

Plain English
This study examined how often critically ill patients in the ICU develop low phosphate levels (hypophosphatemia) during a specific type of kidney treatment called Sustained Low-Efficiency Dialysis (SLED). Researchers found that the incidence of hypophosphatemia increased with the number of dialysis sessions, affecting about 27% of sessions, and that patients receiving phosphate supplements had a significantly lower risk of dying in the ICU, with a mortality rate of 23.1%. Understanding this connection is crucial because managing phosphate levels can lead to better outcomes for patients undergoing dialysis. Who this helps: This helps patients in the ICU who are receiving kidney treatment.

Plain English
This study looked at Burning Mouth Syndrome (BMS), a condition that causes a painful burning sensation in the mouth without any obvious physical cause. It found that worldwide, about 1.73% of people experience BMS, with women and older adults being more likely to be affected. The research highlights that nerve damage in the mouth might play a big role in BMS, and other factors like acid reflux and changes linked to aging could also contribute, but more studies are needed to fully understand the causes. Who this helps: This helps patients suffering from Burning Mouth Syndrome and their doctors.

Plain English
This study looked at how a treatment called L-cysteine can help patients with Chronic Atrophic Gastritis (CAG), a condition that can lead to stomach cancer. After one year, 77 patients taking L-cysteine showed improved stomach function, with increases in a marker called Pepsinogen I and decreases in another marker called gastrin 17, while the group not receiving treatment showed no changes. These findings are important because they suggest that L-cysteine could be a beneficial therapy for CAG patients, potentially reducing their risk of developing stomach cancer. Who this helps: This helps patients with Chronic Atrophic Gastritis.

Plain English
This research paper looks at how to effectively diagnose and treat Helicobacter pylori (H. pylori) infection, which affects more than one-third of adults in Italy and can lead to serious stomach conditions. The study found that treatment is becoming more difficult because the bacteria are increasingly resistant to antibiotics. The guidelines created by experts aim to help doctors choose the best tests and treatments for patients with H. pylori infections. Who this helps: These guidelines primarily benefit doctors and patients suffering from H. pylori-related conditions.

Plain English
This study looked at ways to improve the use of upper gastrointestinal endoscopies (UGIE), which are procedures used to examine the digestive tract. Out of 5,102 requests for these procedures, 540 (or 10.4%) were found to be unnecessary. By using a non-invasive test to evaluate stomach function instead, the researchers were able to make better decisions about who really needed the procedure, ultimately seeing that 67.5% of those who did undergo the endoscopy had normal results—and no cases of cancer were found. Who this helps: This benefits patients who are at risk of unnecessary procedures and helps doctors make better decisions about treatment options.

Plain English
This study looked at the connection between burning mouth syndrome (BMS) and gastroesophageal reflux disease (GERD). Researchers found that among 500 GERD patients, 56 reported BMS, which is a similar rate to other conditions like chronic cough and pharyngitis. They also discovered that most BMS patients had low levels of a specific marker (G17), and treatment with barrier drugs was more effective than traditional acid-reducing medications for relieving their symptoms. Who this helps: This research benefits patients suffering from both burning mouth syndrome and GERD, as it identifies more effective treatment options for them.

Plain English
This paper outlines new guidelines for preventing, diagnosing, and treating Lyme disease, developed by experts from three major medical organizations. The guidelines discuss various aspects of Lyme disease including its prevention and treatment, particularly when it leads to complications such as skin, nerve, heart, or joint problems. Clear recommendations help healthcare providers give better care and ensure patients receive appropriate treatment promptly. Who this helps: Patients with Lyme disease and the doctors treating them.

Plain English
This study created updated guidelines for preventing, diagnosing, and treating Lyme disease, involving experts from three major medical organizations. It focuses on various aspects of Lyme disease, including its most common skin rash and more complex cases affecting the nervous system, heart, or joints. These guidelines are crucial because they help ensure that healthcare providers have the most current information to effectively manage Lyme disease. Who this helps: This helps patients with Lyme disease and the doctors who treat them.

Plain English
This research paper outlines updated guidelines for preventing, diagnosing, and treating Lyme disease, created by experts from several major medical organizations. The guidelines cover various aspects, such as recognizing symptoms like a distinctive skin rash and addressing complications that affect the nervous system, heart, and joints. This is important because Lyme disease can lead to serious health issues if not properly treated. Who this helps: These guidelines benefit doctors and healthcare providers who treat patients with Lyme disease.

Plain English
This study looked at the hormone gastrin 17 (G-17) and its relationship with gastroesophageal reflux disease (GERD). The researchers found that patients with GERD had significantly lower levels of G-17: 1.7 pg/L in a hospital setting and 0.5 pg/L in primary care, compared to levels of 8.9 pg/L and 4.0 pg/L in other patients with similar symptoms. These findings suggest that measuring G-17 could be a non-invasive way to help diagnose GERD, which is important for early and effective treatment. Who this helps: This helps patients experiencing symptoms of GERD.

Plain English
This study looked at using a specific dialysis method called Sustained Low Efficiency Dialysis (SLED) with a special blood thinner for critically ill COVID-19 patients suffering from acute kidney injury (AKI). The researchers found that this approach resulted in fewer blood clotting issues and allowed for longer dialysis treatments without causing serious side effects or worsening patients' conditions. This matters because it provides a safer way to manage kidney problems in these vulnerable patients, potentially leading to better outcomes. Who this helps: Patients with COVID-19-related kidney issues.

Plain English
This study looked at how common a condition called symptomatic uncomplicated diverticular disease (SUDD) is among people who have diverticulosis. Researchers found that only 6.81% of patients with diverticulosis had SUDD, which is lower than what many had thought; additionally, 1.89% had post-diverticulitis SUDD, and 6.38% had symptoms similar to irritable bowel syndrome (IBS). Understanding the actual prevalence helps doctors better diagnose and treat patients with abdominal pain, especially as many may be experiencing IBS or other issues instead. Who this helps: This benefits patients and doctors by improving diagnosis and treatment options.

Plain English
This study looked at how ultrasound can be used to measure changes in thigh muscle thickness in critically ill patients with acute kidney injury (AKI) during their time in the ICU. Researchers found that, on average, the muscle thickness decreased by 15% within just five days of ICU admission. This is important because patients who lost more muscle were less likely to go home after treatment, indicating that monitoring muscle health could be crucial for better outcomes. Who this helps: This benefits patients in ICU and their doctors by providing a way to track muscle health during hospital stays.

Plain English
This study looked at a rare condition called Ménétrier disease in a female patient by measuring two important substances in the blood: pepsinogen I and gastrin 17. The researchers found unusually high levels of pepsinogen I at 1940 mcg/L (normal levels are 30-160 mcg/L) and gastrin 17 at 139 pg/L (normal levels are 1-10 pg/L). These findings highlight how Ménétrier disease can lead to extreme changes in stomach function, which is important for understanding the disease and improving treatment options. Who this helps: This helps patients with Ménétrier disease and their doctors.